Kallyope picks up $112m Series C
New York City-based Kallyope Inc., a biotechnology company, has secured $112 million in Series C financing.
New York City-based Kallyope Inc., a biotechnology company, has secured $112 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination
